atropine has been researched along with 1-(1-pyrrolidinylmethyl)-2-naphthol in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (1-(1-pyrrolidinylmethyl)-2-naphthol) | Trials (1-(1-pyrrolidinylmethyl)-2-naphthol) | Recent Studies (post-2010) (1-(1-pyrrolidinylmethyl)-2-naphthol) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 9 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, AY; Teng, CM; Wang, JS | 1 |
1 other study(ies) available for atropine and 1-(1-pyrrolidinylmethyl)-2-naphthol
| Article | Year |
|---|---|
Studies on the cardiovascular action of TPY-beta: an antihypertensive agent with antiplatelet activity.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Atropine; Blood Pressure; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; In Vitro Techniques; Injections, Intravenous; Male; Microinjections; Muscarinic Antagonists; Muscle, Smooth, Vascular; Naphthols; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrrolidines; Rabbits; Rats; Rats, Wistar; Solitary Nucleus; Vagotomy | 1999 |